Harada Toshiyuki, Nakagawa Yoshiaki, Wadkins Randy M, Potter Philip M, Wheelock Craig E
Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan.
Bioorg Med Chem. 2009 Jan 1;17(1):149-64. doi: 10.1016/j.bmc.2008.11.008. Epub 2008 Nov 9.
Carboxylesterases are enzymes that hydrolyze a broad suite of endogenous and exogenous ester-containing compounds to the corresponding alcohol and carboxylic acid. These enzymes metabolize a number of therapeutics including the anti-tumor agent CPT-11, the anti-viral drug oseltamivir, and the anti-thrombogenic agent clopidogrel as well as many agrochemicals. In addition, carboxylesterases are involved in lipid homeostasis, including cholesterol metabolism and transport with a proposed role in the development of atherosclerosis. Several different scaffolds capable of inhibiting carboxylesterases have been reported, including organophosphates, carbamates, trifluoromethyl ketone-containing structures (TFKs), and aromatic ethane-1,2-diones. Of these varied groups, only the 1,2-diones evidence carboxylesterase isoform-selectivity, which is an important characteristic for therapeutic application and probing biological mechanisms. This study constructed a series of classical and 3D-QSAR models to examine the physiochemical parameters involved in the observed selectivity of three mammalian carboxylesterases: human intestinal carboxylesterase (hiCE), human carboxylesterase 1 (hCE1), and rabbit carboxylesterase (rCE). CoMFA-based models for the benzil-analogs described 88%, 95% and 76% of observed activity for hiCE, hCE1 and rCE, respectively. For TFK-containing compounds, two distinct models were constructed using either the ketone or gem-diol form of the inhibitor. For all three enzymes, the CoMFA ketone models comprised more biological activity than the corresponding gem-diol models; however the differences were small with described activity for all models ranging from 85-98%. A comprehensive model incorporating both benzil and TFK structures described 92%, 85% and 87% of observed activity for hiCE, hCE1 and rCE, respectively. Both classical and 3D-QSAR analysis showed that the observed isoform-selectivity with the benzil-analogs could be described by the volume parameter. This finding was successfully applied to examine substrate selectivity, demonstrating that the relative volumes of the alcohol and acid moieties of ester-containing substrates were predictive for whether hydrolysis was preferred by hiCE or hCE1. Based upon the integrated benzil and TFK model, the next generation inhibitors should combine the A-ring and the 1,2-dione of the benzil inhibitor with the long alkyl chain of the TFK-inhibitor in order to optimize selectivity and potency. These new inhibitors could be useful for elucidating the role of carboxylesterase activity in fatty acid homeostasis and the development of atherosclerosis as well as effecting the controlled activation of carboxylesterase-based prodrugs in situ.
羧酸酯酶是一类能够将多种内源性和外源性含酯化合物水解为相应醇和羧酸的酶。这些酶参与多种治疗药物的代谢,包括抗肿瘤药物伊立替康、抗病毒药物奥司他韦、抗血栓药物氯吡格雷以及许多农用化学品。此外,羧酸酯酶还参与脂质稳态调节,包括胆固醇代谢和运输,在动脉粥样硬化的发展中可能发挥作用。已有报道多种能够抑制羧酸酯酶的不同支架结构,包括有机磷酸酯、氨基甲酸酯、含三氟甲基酮的结构(TFK)以及芳香乙烷 -1,2 -二酮。在这些不同的类别中,只有1,2 -二酮表现出羧酸酯酶同工型选择性,这对于治疗应用和探究生物学机制是一个重要特征。本研究构建了一系列经典和3D - QSAR模型,以研究三种哺乳动物羧酸酯酶:人肠道羧酸酯酶(hiCE)、人羧酸酯酶1(hCE1)和兔羧酸酯酶(rCE)观察到的选择性所涉及的物理化学参数。基于CoMFA的苯偶酰类似物模型分别描述了hiCE、hCE1和rCE观察到的活性的88%、95%和76%。对于含TFK的化合物,使用抑制剂的酮形式或偕二醇形式构建了两个不同的模型。对于所有三种酶,CoMFA酮模型比相应的偕二醇模型包含更多的生物活性;然而差异较小,所有模型描述的活性范围为85 - 98%。一个结合苯偶酰和TFK结构的综合模型分别描述了hiCE、hCE1和rCE观察到的活性的92%、85%和87%。经典和3D - QSAR分析均表明,观察到的与苯偶酰类似物的同工型选择性可以用体积参数来描述。这一发现成功地应用于研究底物选择性,表明含酯底物的醇和酸部分的相对体积对于hiCE或hCE1是否更倾向于水解具有预测性。基于综合的苯偶酰和TFK模型,下一代抑制剂应将苯偶酰抑制剂的A环和1,2 -二酮与TFK抑制剂的长烷基链结合起来,以优化选择性和效力。这些新的抑制剂可用于阐明羧酸酯酶活性在脂肪酸稳态和动脉粥样硬化发展中的作用,以及实现基于羧酸酯酶的前药在原位的可控活化。